Harvard Bioscience Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$572.38 | $591.94 | 8.32% | 1 | $218.49B |
| DHR | Danaher | Outperform |
10
|
$248.38 | $260.33 | 9.68% | 4 | $183.97B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$234.68 | $284.47 | 18.25% | 8 | $67.80B |
| LONN | Lonza Group | Buy |
16
|
CHF519.60 | CHF516.89 | 14.51% | 8 | CHF37.47B |
| BIO | Bio-Rad Laboratories Inc | Buy |
16
|
$279.83 | $536.80 | 50.09% | 1 | $7.74B |
| MXCT | MaxCyte | Buy |
8
|
£2.97 | £9.66 | 130.30% | 6 | £308.33M |